NO139050C - Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater

Info

Publication number
NO139050C
NO139050C NO2561/73A NO256173A NO139050C NO 139050 C NO139050 C NO 139050C NO 2561/73 A NO2561/73 A NO 2561/73A NO 256173 A NO256173 A NO 256173A NO 139050 C NO139050 C NO 139050C
Authority
NO
Norway
Prior art keywords
nororipavin
tebain
derivatives
preparation
therapeutically active
Prior art date
Application number
NO2561/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO139050B (no
Inventor
Adolf Langbein
Herbert Merz
Gerhard Walther
Klaus Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO139050B publication Critical patent/NO139050B/no
Publication of NO139050C publication Critical patent/NO139050C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO2561/73A 1972-06-21 1973-06-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater NO139050C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2230154A DE2230154A1 (de) 1972-06-21 1972-06-21 N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
NO139050B NO139050B (no) 1978-09-18
NO139050C true NO139050C (no) 1979-01-03

Family

ID=5848276

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2561/73A NO139050C (no) 1972-06-21 1973-06-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater

Country Status (14)

Country Link
US (1) US3931189A (ja)
JP (1) JPS5614673B2 (ja)
AT (7) AT328101B (ja)
BE (1) BE801271A (ja)
CH (7) CH585753A5 (ja)
DE (1) DE2230154A1 (ja)
DK (1) DK141629C (ja)
ES (3) ES416106A1 (ja)
FI (1) FI57261C (ja)
FR (1) FR2189066B1 (ja)
GB (1) GB1431385A (ja)
NL (1) NL7308555A (ja)
NO (1) NO139050C (ja)
SE (1) SE412235B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232026A (en) * 1978-07-20 1980-11-04 Merck & Co., Inc. Diazaditwistanes, and pharmaceutical compositions for treating pain in warm blooded animals containing them
JPS60119848A (ja) * 1983-11-30 1985-06-27 三井建設株式会社 繊維補強コンクリ−ト並びにその施工法
JPS62298530A (ja) * 1986-06-16 1987-12-25 Otsuka Pharmaceut Co Ltd 坐薬用医薬組成物
CN1233645C (zh) * 2001-09-14 2005-12-28 中国人民解放军军事医学科学院毒物药物研究所 新的东罂粟碱衍生物及其医药用途
CN1939920B (zh) * 2005-09-29 2011-08-31 中国人民解放军军事医学科学院毒物药物研究所 东罂粟碱类化合物及其医药用途
KR101343395B1 (ko) 2008-07-30 2013-12-19 퍼듀 퍼머 엘피 부프레노르핀 유사체
JP2021104932A (ja) * 2018-03-30 2021-07-26 日本ケミファ株式会社 モルヒナン誘導体の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3285914A (en) * 1964-06-11 1966-11-15 Smith Kline French Lab 3-n-substituted derivatives of oripavine and thebaine
GB1136764A (en) * 1965-08-13 1968-12-18 Reckitt & Sons Ltd Derivatives of thebaine and oripavine
GB1146272A (en) * 1966-01-17 1969-03-26 Reckitt & Sons Ltd Novel thebaine and oripavine derivatives
GB1223445A (en) * 1968-07-18 1971-02-24 Reckitt & Colmann Prod Ltd Improvements in or relating to derivatives of morphine, their salts, and processes for their preparation
DE2107989A1 (de) * 1971-02-19 1972-09-07 Boehringer Sohn Ingelheim N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
FI57261B (fi) 1980-03-31
ES425015A1 (es) 1976-07-01
AT327409B (de) 1976-01-26
ATA461874A (de) 1975-05-15
FR2189066B1 (ja) 1976-12-31
JPS5614673B2 (ja) 1981-04-06
AT325219B (de) 1975-10-10
BE801271A (fr) 1973-12-21
DE2230154A1 (de) 1974-01-17
ATA462174A (de) 1975-05-15
ATA461974A (de) 1975-05-15
CH585753A5 (ja) 1977-03-15
NO139050B (no) 1978-09-18
ATA462374A (de) 1975-07-15
CH586224A5 (ja) 1977-03-31
FR2189066A1 (ja) 1974-01-25
ATA462274A (de) 1975-04-15
CH594672A5 (ja) 1978-01-13
AT329198B (de) 1976-04-26
DK141629C (da) 1980-09-29
US3931189A (en) 1976-01-06
FI57261C (fi) 1980-07-10
AU5721173A (en) 1975-01-09
GB1431385A (en) 1976-04-07
CH585751A5 (ja) 1977-03-15
ES416106A1 (es) 1976-02-16
ATA462074A (de) 1975-05-15
CH587264A5 (ja) 1977-04-29
NL7308555A (ja) 1973-12-27
AT328099B (de) 1976-03-10
AT328098B (de) 1976-03-10
JPS4954390A (ja) 1974-05-27
DK141629B (da) 1980-05-12
CH594673A5 (ja) 1978-01-13
AT328100B (de) 1976-03-10
CH585752A5 (ja) 1977-03-15
SE412235B (sv) 1980-02-25
AT328101B (de) 1976-03-10
ES425010A1 (es) 1976-06-16

Similar Documents

Publication Publication Date Title
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO793013L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO137440C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner
NO137941C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO139127C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkylaminer
NO138336C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzofuranderivater
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO139050C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
NO138026C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
NO137998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tebain- og oripavin-derivater
NO140299C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner
NO137727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener